Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-28

Clinical Trial Update: Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study sponsored by the University of Nebraska to evaluate cannabidiol (CBD) for PTSD symptoms in adults. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Nebraska | Conditions: PTSD | Phase 2 | Status: RECRUITING